May 11, 2017
Editas Medicine
Editas Medicine Announces Pre-Clinical Data for Program to Treat Sickle Cell Disease and Beta-Thalassemia
May 11, 2017
Rhythm Pharmaceuticals
Rhythm Receives Expanded FDA Breakthrough Therapy Designation for Setmelanotide for Rare Genetic Disorders of Obesity
May 10, 2017
Fulcrum Therapeutics
Fulcrum Therapeutics Announces Additional Series A Financing from GV
May 10, 2017
Magenta Therapeutics
Magenta Therapeutics Announces New Clinical Data on its Lead Expansion Clinical Program, MGTA-456, Presented at American Society of Gene and Cell Therapy Annual Meeting
May 09, 2017
Foundation Medicine
Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights